$53M genetic testing fraud | Walgreens completes CareCentrix deal

Having trouble viewing this email? See the online version

Wednesday, August 31, 2022 Wednesday, August 31, 2022 DOJ accuses lab owner of $53M genetic testing fraud The owner of labs in three states allegedly paid kickbacks and bribes from 2019 to 2021 for unnecessary genetic cancer screening referrals. Read More > Walgreens acquires majority share of CareCentrix Walgreens Boots Alliance completed a $330 million deal to purchase 55% of CareCentrix, a home health benefit management company. Read More > CMS proposes big changes to Medicaid, CHIP enrollment The proposed rule precedes the looming resumption of eligibility redeterminations, which are expected to cause 15 million people to lose benefits when the COVID-19 public health emergency lapses. Read More > Oscar Health loses big customer Oscar Health’s deal with Health First was expected to generate $60 million in revenue in 2022.  Read More > Behavioral health provider shortage strains systems, communities Shortages have disproportionately impacted low-income Americans, as nearly 1 of 4 behavioral health prescribers did not see any Medicaid beneficiaries in 2020, new data shows.  Read More > SPONSORED CONTENT SUBSCRIBE TODAY Unlock your access to Best Places to Work, Most Influential People in Healthcare & more. SUBSCRIBE & SAVE 20% This email was sent to chunduri22.covid@blogger.com Manage My Account | Contact Us   © 2022 Modern Healthcare 130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States Privacy Policy | Terms and Conditions | Unsubscribe